Connection

Miriam Lichtner to Case-Control Studies

Back to Details
This is a "connection" page, showing publications Miriam Lichtner has written about Case-Control Studies.
Miriam Lichtner
Connection Strength
0.127
Case-Control Studies
  1. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia. Front Immunol. 2021; 12:627548.
    View in: PubMed
    Score: 0.057
  2. Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon. PLoS One. 2017; 12(6):e0179400.
    View in: PubMed
    Score: 0.044
  3. Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I). Diabetes Res Clin Pract. 2020 Nov; 169:108454.
    View in: PubMed
    Score: 0.014
  4. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-?)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection. Clin Res Hepatol Gastroenterol. 2017 Dec; 41(6):644-655.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.